Mironid is a biotechnology company that focuses on drug discovery and development. Mironid builds and advances a pipeline of drug development programs targeting cAMP-degrading phosphodiesterase enzymes. The goal is to create novel and differentiated therapies for various diseases with significant unmet medical needs. The company specializes in identifying and validating novel drug targets, particularly in therapeutic areas such as cancer and neurodegenerative diseases. Mironid's work often involves using advanced technologies and methodologies to enhance the drug discovery process, aiming to bring innovative treatments to market more efficiently.